rs16147 — NPY C-399T

NPY rs16147 — The Stress Resilience and Appetite Variant

Neuropeptide Y¹¹ Neuropeptide Y
NPY is a 36-amino-acid peptide and the most abundant neuropeptide in the human brain. It acts through five receptor subtypes (Y1-Y5) to regulate feeding, stress, anxiety, pain, and cardiovascular function (NPY) is the brain's most abundant neuropeptide and one of the most potent appetite-stimulating molecules known. But NPY does far more than drive hunger — it serves as a critical brake on the stress response, dampening anxiety, modulating pain perception, and influencing cardiovascular tone. The rs16147 variant sits in the promoter region of the NPY gene, directly affecting how much NPY your cells produce, particularly under stress. This makes it a rare example of a single variant with documented effects across stress resilience, body weight regulation, migraine susceptibility, and blood pressure.

The Mechanism

The rs16147 T>C substitution occurs 399 base pairs upstream of the NPY gene's transcription start site, in a region that regulates gene expression. The T allele creates a stronger binding site for transcription factors, leading to higher NPY expression, particularly under stress²² higher NPY expression, particularly under stress
Zhang K et al. Association of neuropeptide Y promoter polymorphism (rs16147) with perceived stress and cardiac vagal outflow in humans. Sci Rep, 2016. The C allele reduces transcription factor binding affinity³³ transcription factor binding affinity
The C-variant decreases protein binding compared to the T-allele in electrophoretic mobility shift assays, suggesting weaker promoter activation, resulting in lower NPY output when the system is challenged.

This is not a simple on-off switch. Postmortem brain analysis of 107 human anterior cingulate cortex samples⁴⁴ 107 human anterior cingulate cortex samples
Zhou Z et al. Human NPY promoter variation rs16147:T>C as a moderator of prefrontal NPY gene expression and negative affect. Hum Mutat, 2010 showed that the rs16147 genotype accounts for a meaningful portion of individual variation in NPY mRNA levels in this region — a brain area central to emotional regulation and decision-making. The variant's effects are context-dependent: differences between genotypes become most pronounced under conditions of chronic stress or early adversity.

The Evidence

Stress resilience and mental health. In a study of 1,123 healthy Han Chinese adults⁵⁵ 1,123 healthy Han Chinese adults
Zhang K et al. Association of neuropeptide Y promoter polymorphism (rs16147) with perceived stress and cardiac vagal outflow in humans. Sci Rep, 2016, TT homozygotes showed significantly enhanced cardiac vagal outflow⁶⁶ cardiac vagal outflow
Vagal tone reflects parasympathetic nervous system activity. Higher vagal tone is associated with better stress recovery, emotional regulation, and cardiovascular health under chronic high stress compared to CC homozygotes — indicating greater parasympathetic resilience. No genotype differences emerged in the low-stress group, confirming the gene-by-environment pattern. Research in US military veterans⁷⁷ US military veterans
Watkins LE et al. Association between functional polymorphism in neuropeptide Y gene promoter rs16147 and resilience to traumatic stress in US military veterans. J Clin Psychiatry, 2017 found the T allele protective against PTSD intrusion symptoms in combat-exposed populations. The rs16147 variant also interacts with early childhood adversity to predict anxiety and depressive symptoms in young adults, with the C allele functioning as a vulnerability factor.

Appetite and body weight. NPY is one of the most potent orexigenic⁸⁸ orexigenic
Appetite-stimulating. NPY acts through hypothalamic Y1 and Y5 receptors to increase food intake, with a preferential effect on carbohydrate consumption peptides in the brain. A meta-analysis of 9 studies⁹⁹ meta-analysis of 9 studies
Yeung EH et al. Comprehensive evaluation of the neuropeptide-Y gene variants in the risk of obesity. Obesity, 2015 found the T allele significantly associated with obesity risk (OR 1.27, 95% CI 1.04-1.55), including higher BMI, waist circumference, triglycerides, and body fat percentage. A longitudinal study following 306 individuals from infancy to age 19¹⁰¹⁰ longitudinal study following 306 individuals from infancy to age 19
Hohmann S et al. Increasing association between a neuropeptide Y promoter polymorphism and body mass index during the course of development. Pediatr Obes, 2012 showed the genotype-BMI association strengthens during development, with T-allele carriers diverging progressively from CC homozygotes. The POUNDS LOST trial of 723 subjects¹¹¹¹ POUNDS LOST trial of 723 subjects
Qi Q et al. Neuropeptide Y genotype, central obesity, and abdominal fat distribution. Am J Clin Nutr, 2015 demonstrated that rs16147 genotype modifies the effect of dietary fat on abdominal adiposity — T allele carriers gained more visceral fat on high-fat diets.

Migraine and pain. NPY dose-dependently inhibits dural trigeminal neuron firing¹²¹² inhibits dural trigeminal neuron firing
Martins-Oliveira M et al. Neuropeptide Y inhibits the trigeminovascular pathway through NPY Y1 receptor: implications for migraine. Pain, 2016 through the Y1 receptor, achieving up to 40% suppression of baseline activity. Lower NPY expression (C allele) could theoretically reduce this endogenous pain-braking mechanism. Changes in NPY levels have been documented in migraine patients, and disruption of the NPY system may explain appetite disturbances commonly reported during migraine attacks.

Blood pressure. The same POUNDS LOST trial¹³¹³ POUNDS LOST trial
Zhang X et al. Neuropeptide Y promoter polymorphism modifies effects of a weight-loss diet on 2-year changes of blood pressure. Hypertension, 2012 found that rs16147 genotype modifies blood pressure response to dietary interventions, with differential effects depending on dietary fat content — highlighting NPY's role in sympathetic cardiovascular regulation.

Practical Implications

This variant presents an unusual trade-off. The T allele confers greater stress resilience and enhanced parasympathetic tone under pressure — but also predisposes to higher appetite drive and central fat accumulation, especially on high-fat diets. The C allele is associated with lower obesity risk but greater vulnerability to anxiety and stress-related conditions when exposed to adversity.

The actionable implications depend on your genotype: C allele carriers benefit from targeted stress-buffering strategies and may want to monitor for anxiety symptoms during stressful periods. T allele carriers should be aware of their heightened appetite drive, particularly for carbohydrates, and may benefit from dietary fat moderation to manage abdominal fat accumulation.

Interactions

NPY and BDNF (rs6265) converge on stress resilience pathways. Both neuropeptides are released in an activity-dependent manner and both modulate the HPA axis stress response. Individuals carrying both the NPY rs16147 CC genotype (lower stress-induced NPY) and the BDNF Met allele (rs6265 CT or TT, reduced activity-dependent BDNF release) may experience compounded vulnerability to stress-related mood disturbance, as both endogenous stress-buffering systems are attenuated simultaneously.

NPY also interacts with the HPA axis through FKBP5 (rs1360780). FKBP5 regulates glucocorticoid receptor sensitivity, and impaired NPY stress-braking combined with enhanced glucocorticoid signaling (rs1360780 T allele) could amplify stress reactivity beyond what either variant produces alone.